Apatinib as first-line treatment in patients with advanced hepatocellular carcinoma: a phase II clinical trial

BACKGROUND: The prognosis for advanced hepatocellular carcinoma (HCC) remains clinically unsatisfying. Apatinib has proven to be a very effective treatment for advanced HCC in our previous retrospective study. Our aim in this study was to evaluate the efficacy, safety, and toxicity of apatinib in pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Transl Med
Main Authors: Hou, Zhenyu, Zhu, Keyun, Yang, Xuejiao, Chen, Ping, Zhang, Wei, Cui, Yunlong, Zhu, Xiaolin, Song, Tianqiang, Li, Qiang, Li, Huikai, Zhang, Ti
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7576000/
https://ncbi.nlm.nih.gov/pubmed/33145266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-2990
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados